These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30811904)

  • 1. Opioid Use Disorder and Incarceration - Hope for Ensuring the Continuity of Treatment.
    Binswanger IA
    N Engl J Med; 2019 Mar; 380(13):1193-1195. PubMed ID: 30811904
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescribing Opioid Replacement Therapy in U.S. Correctional Settings.
    Farahmand P; Modesto-Lowe V; Chaplin MM
    J Am Acad Psychiatry Law; 2017 Dec; 45(4):472-477. PubMed ID: 29282239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial Management of Incarcerated Pregnant Women With Opioid Use Disorder.
    O'Connor A; Bowling N
    J Correct Health Care; 2020 Jan; 26(1):17-26. PubMed ID: 31960750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of medications for opioid use disorder before and after incarceration in Massachusetts State prisons, 2014-2019.
    Bovell-Ammon BJ; Yan S; Dunn D; Evans EA; Friedmann PD; Walley AY; LaRochelle MR
    Drug Alcohol Depend; 2024 Sep; 262():111392. PubMed ID: 39029371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication-Based Treatment to Address Opioid Use Disorder.
    Leshner AI; Dzau VJ
    JAMA; 2019 Jun; 321(21):2071-2072. PubMed ID: 31046072
    [No Abstract]   [Full Text] [Related]  

  • 7. "I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.
    Maradiaga JA; Nahvi S; Cunningham CO; Sanchez J; Fox AD
    J Subst Abuse Treat; 2016 Mar; 62():49-54. PubMed ID: 26747509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for Substance Use Disorders.
    Klein JW
    Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.
    Ward HB; Barnett BS; Suzuki J
    Subst Abus; 2019; 40(2):140-145. PubMed ID: 30888254
    [No Abstract]   [Full Text] [Related]  

  • 10. Medication-assisted treatment for opioid use disorder.
    Kaplan L
    Nurse Pract; 2019 Mar; 44(3):10-12. PubMed ID: 30585906
    [No Abstract]   [Full Text] [Related]  

  • 11. A New Way Forward in the Emergency Department.
    Schwarz ES; Laes JR; Wiegand TJ
    J Med Toxicol; 2019 Oct; 15(4):220-222. PubMed ID: 31278586
    [No Abstract]   [Full Text] [Related]  

  • 12. An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
    Brezel ER; Powell T; Fox AD
    Subst Abus; 2020; 41(2):150-154. PubMed ID: 31800376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Opioid-Use Disorders.
    Schuckit MA
    N Engl J Med; 2016 Jul; 375(4):357-68. PubMed ID: 27464203
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
    Soyka M; Hillemacher T
    Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
    Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
    Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
    Marzo JN; Rotily M; Meroueh F; Varastet M; Hunault C; Obradovic I; Zin A
    Addiction; 2009 Jul; 104(7):1233-40. PubMed ID: 19426291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.
    Krawczyk N; Picher CE; Feder KA; Saloner B
    Health Aff (Millwood); 2017 Dec; 36(12):2046-2053. PubMed ID: 29200340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
    Pena E; Ahmed S
    Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.